August 31, 2018 | 1:51 PM by Fahad Khalid

Glaukos (GKOS) – iStent inject for Glaucoma

It pays to do fundamental research. This bullish view was first presented in the 3Q2018 Quarterly Outlook on July 1 with the stock at $40.65. The stock is now at…

Continue Reading »

May 2, 2017 | 8:50 AM by Fahad Khalid

JaguarWebinar – May 2

Please Subscribe or Login to access premium content.

January 11, 2016 | 10:44 PM by Fahad Khalid

Nevro (NVRO) Positioned for Further Upside

This morning Nevro announced preliminary set of earnings, well above consensus view. – Q4 Sales $32.8M vs. $24M consensus – FY2015 Sales $69.3M vs. $60.7M consensus – FY2016 Sales Guidance…

Continue Reading »

Password must meet the following requirements: